Literature DB >> 7954447

Expression of helix-loop-helix factor Id-1 is dependent on the hepatocyte proliferation and differentiation status in rat liver and in primary culture.

C Le Jossic1, G P Ilyin, P Loyer, D Glaise, S Cariou, C Guguen-Guillouzo.   

Abstract

Id proteins are known as negative regulators of differentiation in various cell types. In this report, we show that the Id-1 gene was down-regulated during the development of rat liver. No Id-1 transcripts were detected in terminal differentiated hepatocytes. We have studied Id-1 expression in proliferating hepatocytes using an in vivo model of liver regeneration after partial hepatectomy and an in vitro growth factor-stimulated hepatocyte culture system. Strong activation of Id-1 was observed in mid-late G1 of the hepatocyte cell cycle at a time corresponding to a mitogen restriction point. These observations suggest that Id-1 is involved in the control of proliferation and differentiation in liver cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954447

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation.

Authors:  Junwon Lee; Kabsun Kim; Jung Ha Kim; Hye Mi Jin; Han Kyung Choi; Seoung-Hoon Lee; Hyun Kook; Kyung Keun Kim; Yoshifumi Yokota; Soo Young Lee; Yongwon Choi; Nacksung Kim
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

2.  Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1.

Authors:  P Y Desprez; E Hara; M J Bissell; J Campisi
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

3.  Reticulon 4B (Nogo-B) facilitates hepatocyte proliferation and liver regeneration in mice.

Authors:  Lili Gao; Teruo Utsumi; Keitaro Tashiro; Bo Liu; Dahai Zhang; E Scott Swenson; Yasuko Iwakiri
Journal:  Hepatology       Date:  2013-03-19       Impact factor: 17.425

4.  E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein.

Authors:  D A Loveys; M B Streiff; G J Kato
Journal:  Nucleic Acids Res       Date:  1996-07-15       Impact factor: 16.971

5.  Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors.

Authors:  E Hara; M Hall; G Peters
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

6.  Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis.

Authors:  H Maruyama; J Kleeff; S Wildi; H Friess; M W Büchler; M A Israel; M Korc
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors.

Authors:  M Florio; M C Hernandez; H Yang; H K Shu; J L Cleveland; M A Israel
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Anti-tumor effects of an ID antagonist with no observed acquired resistance.

Authors:  Paulina M Wojnarowicz; Marta Garcia Escolano; Yun-Han Huang; Bina Desai; Yvette Chin; Riddhi Shah; Sijia Xu; Saurabh Yadav; Sergey Yaklichkin; Ouathek Ouerfelli; Rajesh Kumar Soni; John Philip; David C Montrose; John H Healey; Vinagolu K Rajasekhar; William A Garland; Jeremy Ratiu; Yuan Zhuang; Larry Norton; Neal Rosen; Ronald C Hendrickson; Xi Kathy Zhou; Antonio Iavarone; Joan Massague; Andrew J Dannenberg; Anna Lasorella; Robert Benezra
Journal:  NPJ Breast Cancer       Date:  2021-05-24

9.  Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers.

Authors:  Min Khine Maw; Jiro Fujimoto; Teruhiko Tamaya
Journal:  BMC Cancer       Date:  2009-12-10       Impact factor: 4.430

10.  Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers.

Authors:  M K Maw; J Fujimoto; T Tamaya
Journal:  Br J Cancer       Date:  2008-10-28       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.